Gorillacillin and the Tragedy of the Commons
Was I right to prescribe an inferior medication to my patient?
(Read the rest and view comments at Critical Decisions)
Was I right to prescribe an inferior medication to my patient?
(Read the rest and view comments at Critical Decisions)
David Asch and I recently published an article in Health Affairs on the challenge of getting healthcare practitioners to stop doing things they are accustomed to doing, even when the evidence that those things are harmful becomes overwhelming. Here is a teaser from that article, and a link to the full piece: As hard as…
The US isn’t the only country struggling with the high price of prescription drugs. A decade ago, Germany was facing rapidly rising medication prices. In 2011, it struck back, with a law regulating the price of new medications. Here’s how that law works, and what it has meant for whether Germans have access to new…
In a recent Health Affairs article, David Asch and I wrote about how hard it can be to stop screening aggressively for things like breast and prostate cancer even when the evidence suggests we are doing more harm than good. Well, journalist Steven Petrow has a nice piece in the Washington Post looking at the…
KARAN: You referred to patient education earlier, not just in terms of treatment information but also the types of questions to be asking. But what about the former? Our generation is definitely comfortable using technology to look up health information, and we get a ton of information through news, magazines, and the general media. But…
Imagine picking up a telephone and hearing your doctor tell you there is a “999 out of 1,000 chance that you’ll be dead within a decade.” That’s what Leonard Mlodinow experienced in 1989, when his routine HIV test didn’t turn out the way he expected. Mlodinow tells this story in his 2008 book, The Drunkard’s Walk,…
If an antibiotic would cure your infection, your doctor would probably still warn you about the chance of sun sensitivity before prescribing the pill. But even when the costs of a medical intervention might force patients to choose between paying the bill or keeping up with their mortgages, American physicians rarely discuss that serious side effect with…